Paola Chiarugi

Paola Chiarugi's AcademicInfluence.com Rankings

Paola Chiarugi

Physics

#7619

World Rank

#9664

Historical Rank

physics Degrees

Download Badge

Physics

Paola Chiarugi's Degrees

PhD Physics University of Florence
Masters Physics University of Florence
Bachelors Physics University of Florence

Why Is Paola Chiarugi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paola Chiarugi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Anoikis molecular pathways and its role in cancer progression. (2013) (803)
Rac and Rho GTPases in cancer cell motility control (2010) (576)
Cancer associated fibroblasts: the dark side of the coin. (2011) (520)
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. (2010) (504)
Anoikis: a necessary death program for anchorage-dependent cells. (2008) (465)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression (2012) (460)
Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. (2012) (424)
Intracellular Reactive Oxygen Species Activate Src Tyrosine Kinase during Cell Adhesion and Anchorage-Dependent Cell Growth (2005) (420)
Anoikis: an emerging hallmark in health and diseases (2012) (382)
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression (2014) (357)
Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. (2003) (329)
HNE interacts directly with JNK isoforms in human hepatic stellate cells. (1998) (290)
Metastasis: cancer cell’s escape from oxidative stress (2010) (279)
Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison (2012) (271)
Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion (2003) (264)
Microenvironment and tumor cell plasticity: an easy way out. (2013) (218)
Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. (2007) (210)
Two Vicinal Cysteines Confer a Peculiar Redox Regulation to Low Molecular Weight Protein Tyrosine Phosphatase in Response to Platelet-derived Growth Factor Receptor Stimulation* (2001) (196)
Lactate: A Metabolic Driver in the Tumour Landscape. (2019) (195)
Reactive oxygen species as essential mediators of cell adhesion (2003) (193)
Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. (2011) (182)
EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. (2012) (178)
Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. (2013) (174)
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies. (2018) (164)
ReviewPTPs versus PTKs: The redox side of the coin (2005) (160)
Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. (2007) (159)
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival (2008) (142)
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. (2009) (137)
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. (2011) (133)
Redox signalling in anchorage-dependent cell growth. (2007) (131)
Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals (2009) (131)
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma‐Associated Fibroblasts by Prostate Cancer Microenvironment‐Derived TGF‐β1 (2016) (131)
The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy (2014) (129)
Low molecular weight protein tyrosine phosphatases: small, but smart (2002) (128)
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells (2013) (122)
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer (2019) (121)
Redox Regulation of β-Actin during Integrin-mediated Cell Adhesion* (2006) (120)
LMW-PTP is a positive regulator of tumor onset and growth (2004) (115)
PDGF receptor as a specific in vivo target for low M r phosphotyrosine protein phosphatase (1995) (114)
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. (1997) (111)
Src redox regulation: again in the front line. (2010) (109)
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (2017) (108)
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis (2019) (106)
MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer. (2017) (106)
Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. (2009) (105)
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells (2016) (101)
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors (2017) (99)
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits (2015) (98)
The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. (1993) (95)
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. (2007) (94)
Senescent stroma promotes prostate cancer progression: The role of miR‐210 (2014) (94)
Redox-based escape mechanism from death: the cancer lesson. (2009) (93)
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression (2014) (90)
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. (2002) (88)
EphrinA1 Activates a Src/Focal Adhesion Kinase-mediated Motility Response Leading to Rho-dependent Actino/Myosin Contractility* (2007) (87)
The Low M r Protein-tyrosine Phosphatase Is Involved in Rho-mediated Cytoskeleton Rearrangement after Integrin and Platelet-derived Growth Factor Stimulation* (2000) (87)
Metabolic exchanges within tumor microenvironment. (2016) (85)
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. (1999) (85)
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines (2013) (85)
Reactive oxygen species as mediators of cell adhesion. (2003) (85)
EphrinA1 Repulsive Response Is Regulated by an EphA2 Tyrosine Phosphatase* (2005) (85)
The Src and Signal Transducers and Activators of Transcription Pathways As Specific Targets for Low Molecular Weight Phosphotyrosine-protein Phosphatase in Platelet-derived Growth Factor Signaling* (1998) (84)
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread (2015) (82)
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells (2014) (80)
The low M r phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase (1999) (80)
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor (2009) (73)
Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species (2012) (73)
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression (2014) (73)
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. (2016) (72)
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells (2017) (72)
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis (2016) (71)
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. (1997) (71)
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. (2012) (70)
miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts. (2014) (67)
EphA2 Induces Metastatic Growth Regulating Amoeboid Motility and Clonogenic Potential in Prostate Carcinoma Cells (2011) (66)
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation (2015) (64)
Globular adiponectin induces differentiation and fusion of skeletal muscle cells (2009) (62)
Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness (2012) (61)
Redox circuitries driving Src regulation. (2014) (57)
The Molecular Basis of the Differing Kinetic Behavior of the Two Low Molecular Mass Phosphotyrosine Protein Phosphatase Isoforms (*) (1996) (55)
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts (2014) (54)
From anchorage dependent proliferation to survival: Lessons from redox signalling (2008) (53)
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer (2019) (53)
Low Molecular Weight Protein-tyrosine Phosphatase Tyrosine Phosphorylation by c-Src during Platelet-derived Growth Factor-induced Mitogenesis Correlates with Its Subcellular Targeting* (1998) (52)
Tumor microenvironment and metabolism in prostate cancer. (2014) (50)
New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases. (2002) (50)
Chronic resveratrol treatment ameliorates cell adhesion and mitigates the inflammatory phenotype in senescent human fibroblasts. (2013) (50)
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer (2014) (50)
Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration (2010) (47)
Src redox regulation: there is more than meets the eye. (2008) (47)
Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. (2012) (47)
Aspartic‐129 is an essential residue in the catalytic mechanism of the low M r phosphotyrosine protein phosphatase (1994) (46)
Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition (2018) (45)
Low Molecular Weight Protein-tyrosine Phosphatase Is Involved in Growth Inhibition during Cell Differentiation* (2001) (44)
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition. (2013) (44)
In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide (1995) (43)
Redox molecular machines involved in tumor progression. (2013) (43)
The Redox Regulation of LMW‐PTP During Cell Proliferation or Growth Inhibition (2001) (42)
Lymphocyte Function-associated Antigen-1-mediated T Cell Adhesion Is Impaired by Low Molecular Weight Phosphotyrosine Phosphatase-dependent Inhibition of FAK Activity* (2003) (41)
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style (2014) (41)
Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site. (1996) (40)
Insight into the Role of Low Molecular Weight Phosphotyrosine Phosphatase (LMW-PTP) on Platelet-derived Growth Factor Receptor (PDGF-r) Signaling (2002) (40)
EphA2-mediated mesenchymal–amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts (2012) (40)
Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells (2009) (39)
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. (2021) (39)
Redox Regulation of Ephrin/Integrin Cross-Talk (2007) (38)
β3‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma (2019) (37)
Cancer-associated fibroblasts and macrophages (2013) (36)
Globular Adiponectin as a Complete Mesoangioblast Regulator: Role in Proliferation, Survival, Motility, and Skeletal Muscle Differentiation (2010) (36)
LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. (2000) (36)
Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk. (2016) (35)
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy (2020) (30)
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin (2006) (30)
Globular Adiponectin Activates Motility and Regenerative Traits of Muscle Satellite Cells (2012) (30)
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (29)
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival. (2016) (28)
Metabolic implication of tumor:stroma crosstalk in breast cancer (2014) (27)
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival. (2016) (27)
Differential role of four cysteines on the activity of a low M r phosphotyrosine protein phosphatase (1992) (27)
Redox‐dependent and ligand‐independent trans‐activation of insulin receptor by globular adiponectin (2007) (27)
A novel redox-based switch: LMW-PTP oxidation enhances Grb2 binding and leads to ERK activation. (2006) (26)
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts (2016) (26)
22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis (2012) (26)
Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness (2020) (25)
Low Molecular Weight Protein-tyrosine Phosphatase Controls the Rate and the Strength of NIH-3T3 Cells Adhesion through Its Phosphorylation on Tyrosine 131 or 132* (2000) (24)
β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells (2018) (23)
Anchorage-dependent cell growth: tyrosine kinases and phosphatases meet redox regulation. (2005) (22)
Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib (2020) (19)
The effects of CA IX catalysis products within tumor microenvironment (2013) (19)
Stromal‐induced downregulation of miR‐1247 promotes prostate cancer malignancy (2018) (19)
Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time. (2017) (19)
Endostatin: A Promising Drug for Antiangiogenic Therapy (1999) (19)
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer (2016) (18)
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product (2020) (17)
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits (2016) (17)
Cloning and expression of the cDNA coding for the erythrocyte isoenzyme of human acylphosphatase (1995) (17)
Acylphosphatase is involved in differentiation of K562 cells (1997) (17)
The "click-on-tube" approach for the production of efficient drug carriers based on oxidized multi-walled carbon nanotubes. (2016) (16)
Insulin inhibits platelet-derived growth factor-induced cell proliferation. (2004) (16)
The role of Cys-17 in the pyridoxal 5'-phosphate inhibition of the bovine liver low M(r) phosphotyrosine protein phosphatase. (1993) (16)
Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression (2020) (15)
Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression (2020) (15)
The 5′‐untranslated region of the human muscle acylphosphatase mRNA has an inhibitory effect on protein expression (1997) (14)
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. (2022) (14)
Differential modulation of expression of the two acylphosphatase isoenzymes by thyroid hormone. (1995) (13)
Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatases (2005) (12)
Reactive Oxygen Species: Friends and Foes of Signal Transduction (2012) (12)
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis (2003) (12)
Differential migration of acylphosphatase isoenzymes from cytoplasm to nucleus during apoptotic cell death. (1997) (12)
The inhibitory effect of the 5′ untranslated region of muscle acylphosphatase mRNA on protein expression is relieved during cell differentiation (2000) (12)
Survival or death: the redox paradox. (2009) (11)
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX). (2017) (11)
Multivalent presentation of a hydrolytically stable GM(3) lactone mimetic as modulator of melanoma cells motility and adhesion. (2013) (11)
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression (2011) (10)
Redox Regulation of Nonmuscle Myosin Heavy Chain during Integrin Engagement (2011) (10)
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis. (2022) (8)
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches (2021) (7)
Preferential accumulation of muscle type acylphosphatase in the nucleus during differentiation (1999) (7)
Metabolic cell communication within tumour microenvironment: models, methods and perspectives. (2020) (7)
β3-adrenoreceptor and tumor microenvironment: a new hub (2015) (7)
Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness. (2020) (6)
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells. (2019) (6)
The role of His66 and His72 in the reaction mechanism of bovine liver low-M(r) phosphotyrosine protein phosphatase. (1994) (5)
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) (2021) (5)
Role of a Preorganized Scaffold Presenting Four Residues of a GM-3 Lactone Mimetic on Melanoma Progression. (2016) (5)
Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer (2022) (5)
as essential mediators of cell survival (2008) (4)
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (2017) (4)
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer. (2021) (4)
Cancer stemness and progression: mitochondria on the stage (2015) (4)
β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance (2020) (4)
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (2018) (3)
Tumors and their stroma (2013) (3)
Faculty Opinions recommendation of Redox regulation of cAMP-dependent protein kinase signaling: kinase versus phosphatase inactivation. (2007) (2)
Conjugation of a GM3 lactone mimetic on carbon nanotubes enhances the related inhibition of melanoma-associated metastatic events. (2018) (2)
Cytokine Receptor Signal Transduction Mechanisms in Immuno-Hematopoietic Cells (1993) (2)
Cancer and Ageing 2:Tumor microenvironment and oxidative stress: involvement in metabolic reprogramming and chemo-resistance of prostate cancer cells (2012) (2)
Unconventional roles of lactate along the tumor and immune landscape (2022) (2)
The metabolic gene HAO2 is downregulated in mouse, rat and human hepatocellular carcinoma and correlates with metastasis and poor survival (2016) (2)
The low Mr phosphotyrosine protein phosphatase behaves di¡erently when phosphorylated at Tyr 131 or Tyr 132 by Src kinase (1999) (2)
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (2)
Tumors and their microenvironment (2021) (2)
Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells (2010) (2)
Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells (2021) (2)
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (1)
Angiogenesis , Metastasis , and the Cellular Microenvironment EphA 2 Induces Metastatic Growth Regulating Amoeboid Motility and Clonogenic Potential in Prostate Carcinoma Cells (2011) (1)
Abstract B18: MiR-205 puts the brakes on the malignant interplay between prostate cancer cells and associated fibroblasts (2013) (1)
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer (2013) (1)
Abstract 1009: Metabolic reprogramming discriminates aggressive vs. slowly growing preneoplastic lesions at early stages of HCC development (2016) (1)
An in vitro molecular study of the Nicotiana tabacum L. genome in the presence or absence of the herbicide atrazine (1998) (1)
Principles of Redox Signaling (2015) (1)
Nutritional and metabolic signalling through GPCRs (2022) (1)
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (2018) (1)
312: Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts (2014) (1)
Cancer-associated fibroblasts drive the transfer and reeducation of mitochondria in prostate cancer (2018) (1)
During muscle ageing the activation of the mitogenic signalling is not sufficient to guarantee cellular duplication. (2005) (1)
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression (2014) (1)
Tumor and Stem Cell Biology Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately In fl uences Tumor-Stroma Interplay (2012) (1)
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells (2014) (1)
Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’ [ESMO Open Volume 6, Issue 3, June 2021, 100165] (2021) (0)
The effects of CA IX catalysis products within tumor microenvironment (2013) (0)
Faculty Opinions recommendation of Rac activation and inactivation control plasticity of tumor cell movement. (2009) (0)
EphA2-mediated mesenchymal–amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts (2012) (0)
274: Tumor metabolism and docetaxel resistance in prostate cancer (2014) (0)
Detection of Released CO2 by Radioactive Lactate (2013) (0)
Abstract 1769: A novel potential cancer marker and therapeutic target (2014) (0)
Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of non-alcoholic fatty liver disease (NAFLD) (2020) (0)
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer (2020) (0)
Differential modulation ofexpression ofthetwoacylphosphatase isoenzymes bythyroid hormone (1995) (0)
ACYLPHOSPHATASE LEVEL IN K562 CELLS IS CORRELATED WITH DIFFERENTIATION (1996) (0)
Reprogramming of amino acid transporters induces Aspartate and Glutamate dependency and drives endocrine resistance in breast cancer (2020) (0)
Faculty Opinions recommendation of Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. (2004) (0)
Analysis of the Incorporation of Carbon Atoms from Radioactive Lactate into Proteins (2013) (0)
Mesenchymal Stem Cells are Recruited and Activated into CarcinomaAssociated Fibroblasts by Prostate Cancer MicroenvironmentDerived TGF1 (2016) (0)
Mitochondrial oxidative metabolism contributes to maintain a cancer stem cell phenotype in cholangiocarcinoma (2020) (0)
Abstract 4384A: A novel potential therapeutic target for breast, lung, ovary and colon cancer (2015) (0)
Abstract A02: OXPHOS inhibition and pentose phosphate pathway induction are early events priming preneoplastic lesions toward HCC development (2016) (0)
DNA rearrangements and multiplicity changes in tobacco somaclones susceptible or tolerant to atrazine. (1989) (0)
FRI-321-Hepatocyte expression of the protein kinase ERK5 regulates insulin sensitivity (2019) (0)
297: The metabolic cooperation between prostate carcinoma cells and cancer associated fibroblasts: pyruvate kinase M2 at the crossroads (2014) (0)
278 ROLE OF STROMAL FIBROBLASTS INTERACTION WITH PROSTATIC CANCER CELLS IN ACHIEVEMENT OF METASTATIC PHENOTYPE (2010) (0)
549 A novel cancer marker and potential therapeutic target (2014) (0)
Metabolic implication of tumor:stroma crosstalk in breast cancer (2014) (0)
Faculty Opinions recommendation of Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. (2007) (0)
Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative glucose metabolism (2018) (0)
Advances in Brief Herpes Simplex Virus Thymidine Kinase / Ganciclovir-mediated Apoptotic Death of Bystander Cells 1 (2006) (0)
126: Metabolic and motile reprogramming of ER positive breast cancer cells following long-term estrogen deprivation (2014) (0)
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling (2023) (0)
Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative metabolism (2019) (0)
THU-488-Acquisition of stem-like features in cholangiocarcinoma is associated with an oxidative metabolism (2019) (0)
Faculty Opinions recommendation of Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. (2003) (0)
Integration of gene expression and miRNAs reveals amino acid metabolism as key metabolic hub of adaptation to long term oestrogen deprivation in ER+ breast cancer cells (2016) (0)
Metabolic Reprogramming toward Awarburg Phenotype Characterizes Early Phases of Hepatic Carcinogenesis (2016) (0)
Faculty Opinions recommendation of Redox-mediated substrate recognition by Sdp1 defines a new group of tyrosine phosphatases. (2007) (0)
Coordinately Influences Tumor-Stroma Interplay Reciprocal Metabolic Reprogramming through Lactate Shuttle (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paola Chiarugi?

Paola Chiarugi is affiliated with the following schools:

Consorzio ICoN
University of Siena
University of Florence